Ji‐Feng Feng

2.9k total citations
51 papers, 1.1k citations indexed

About

Ji‐Feng Feng is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ji‐Feng Feng has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Surgery, 40 papers in Oncology and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ji‐Feng Feng's work include Esophageal Cancer Research and Treatment (42 papers), Inflammatory Biomarkers in Disease Prognosis (30 papers) and Gastric Cancer Management and Outcomes (16 papers). Ji‐Feng Feng is often cited by papers focused on Esophageal Cancer Research and Treatment (42 papers), Inflammatory Biomarkers in Disease Prognosis (30 papers) and Gastric Cancer Management and Outcomes (16 papers). Ji‐Feng Feng collaborates with scholars based in China, Taiwan and United States. Ji‐Feng Feng's co-authors include Ying Huang, Xun Yang, Qixun Chen, Qixun Chen, Sheng Chen, Qiang Zhao, Liang Wang, Qiang Zhao, Liang Wang and Jianming Zhao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Ji‐Feng Feng

48 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ji‐Feng Feng China	19	801	497	328	190	96	51	1.1k
Campbell SD Roxburgh United Kingdom	8	797 1.0×	270 0.5×	230 0.7×	237 1.2×	76 0.8×	22	924
Akira Iwaku Japan	8	620 0.8×	274 0.6×	196 0.6×	251 1.3×	204 2.1×	16	866
Akiyoshi Kinoshita Japan	15	739 0.9×	364 0.7×	245 0.7×	322 1.7×	333 3.5×	43	1.2k
Nao Fushiya Japan	8	628 0.8×	260 0.5×	177 0.5×	275 1.4×	214 2.2×	15	874
Mesut Şeker Türkiye	17	615 0.8×	410 0.8×	488 1.5×	174 0.9×	147 1.5×	98	1.3k
Xun Yang China	14	377 0.5×	274 0.6×	178 0.5×	99 0.5×	61 0.6×	47	574
Kazuhiro Migita Japan	20	646 0.8×	590 1.2×	587 1.8×	129 0.7×	83 0.9×	61	1.2k
Mutumi Oishi Japan	7	579 0.7×	222 0.4×	153 0.5×	244 1.3×	191 2.0×	7	781
Xin An China	15	839 1.0×	423 0.9×	183 0.6×	201 1.1×	58 0.6×	29	1.0k
Akito Matsukuma Japan	14	576 0.7×	463 0.9×	543 1.7×	191 1.0×	158 1.6×	33	1.2k

Countries citing papers authored by Ji‐Feng Feng

Since Specialization

Citations

This map shows the geographic impact of Ji‐Feng Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji‐Feng Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji‐Feng Feng more than expected).

Fields of papers citing papers by Ji‐Feng Feng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji‐Feng Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji‐Feng Feng. The network helps show where Ji‐Feng Feng may publish in the future.

Co-authorship network of co-authors of Ji‐Feng Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Ji‐Feng Feng. A scholar is included among the top collaborators of Ji‐Feng Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji‐Feng Feng. Ji‐Feng Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feng, Ji‐Feng, Liang Wang, Xun Yang, & Qixun Chen. (2025). The systemic oxidative stress index predicts clinical outcomes of esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy. Frontiers in Immunology. 16. 1535507–1535507.

Feng, Ji‐Feng, Liang Wang, Xun Yang, Qixun Chen, & Xiangdong Cheng. (2024). Clinical significance of geriatric nutritional risk index in esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy. European Journal of Surgical Oncology. 50(6). 108323–108323. 1 indexed citations

Zhang, Qingyuan, Kunwei Shen, Quchang Ouyang, et al.. (2024). Abemaciclib combined with endocrine therapy as adjuvant treatment for hormone-receptor-positive, HER2−, high-risk early breast cancer: 5-year Chinese population analysis of the phase III randomized monarchE study. Therapeutic Advances in Medical Oncology. 16. 12731511–12731511. 2 indexed citations

Feng, Ji‐Feng, Liang Wang, Xun Yang, Qixun Chen, & Xiangdong Cheng. (2023). Comprehensive nutritional index predicts clinical outcomes for esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy. International Immunopharmacology. 121. 110459–110459. 3 indexed citations

Feng, Ji‐Feng, Liang Wang, Xun Yang, Qixun Chen, & Xiangdong Cheng. (2023). Clinical utility of preoperative pan-immune-inflammation value (PIV) for prognostication in patients with esophageal squamous cell carcinoma. International Immunopharmacology. 123. 110805–110805. 18 indexed citations

Chen, Pengcheng, Liang Wang, Xun Yang, & Ji‐Feng Feng. (2023). Lymph node ratio is a prognostic indicator for locally advanced esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy. SHILAP Revista de lepidopterología. 24(1). 159–169. 2 indexed citations

Feng, Ji‐Feng, Liang Wang, Xun Yang, Qixun Chen, & Xiangdong Cheng. (2023). ASO Author Reflections: A Novel, Sensitive, and Effective Index in Predicting Therapeutic Response of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 31(1). 241–242. 1 indexed citations

Feng, Ji‐Feng, Liang Wang, Xun Yang, Qixun Chen, & Xiangdong Cheng. (2022). Pathologic Complete Response Prediction to Neoadjuvant Immunotherapy Combined with Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: Real-World Evidence from Integrative Inflammatory and Nutritional Scores. Journal of Inflammation Research. Volume 15. 3783–3796. 13 indexed citations

Feng, Ji‐Feng, Liang Wang, Xun Yang, Qixun Chen, & Xiangdong Cheng. (2022). Prediction of pathologic complete response prediction in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy: A real-world study. SHILAP Revista de lepidopterología. 23(1). 153–160. 7 indexed citations

10.

Feng, Ji‐Feng, et al.. (2021). Development and validation a novel preoperative comprehensive prognostic score based on inflammatory and nutritional score, coagulation indicator and tumor marker in esophageal squamous cell carcinoma. Bosnian Journal of Basic Medical Sciences. 22(3). 460–470. 2 indexed citations

11.

Feng, Ji‐Feng, Jianming Zhao, Sheng Chen, & Qixun Chen. (2021). Naples Prognostic Score: A Novel Prognostic Score in Predicting Cancer-Specific Survival in Patients With Resected Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 11. 652537–652537. 32 indexed citations

12.

Feng, Ji‐Feng, et al.. (2020). Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma. Journal of Cancer. 11(6). 1334–1340. 20 indexed citations

13.

Feng, Ji‐Feng, Sheng Chen, Qiang Zhao, & Pengcheng Chen. (2019). Prognostic value of mean platelet volume/platelet count ratio in patients with resectable esophageal squamous cell carcinoma: a retrospective study. PeerJ. 7. e7246–e7246. 12 indexed citations

14.

Wang, Feng, Chao Ren, Qi Zhao, et al.. (2019). Association of frequent amplification of chromosome 11q13 in esophageal squamous cell cancer with clinical benefit to immune check point blockade.. Journal of Clinical Oncology. 37(15_suppl). 4036–4036. 19 indexed citations

15.

Feng, Ji‐Feng, et al.. (2016). Prognostic Value of Plasma D-dimer in Patients with Resectable Esophageal Squamous Cell Carcinoma in China. Journal of Cancer. 7(12). 1663–1667. 22 indexed citations

16.

Feng, Ji‐Feng, et al.. (2014). Lymphopenia Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma. Medicine. 93(27). e257–e257. 70 indexed citations

17.

Feng, Ji‐Feng, Ying Huang, Qiang Zhao, & Qixun Chen. (2013). Clinical Significance of Preoperative Neutrophil Lymphocyte Ratio versus Platelet Lymphocyte Ratio in Patients with Small Cell Carcinoma of the Esophagus. The Scientific World JOURNAL. 2013(1). 504365–504365. 59 indexed citations

18.

Feng, Ji‐Feng, Ying Huang, & Qixun Chen. (2013). Prognostic Value of Preoperative Serum CA 242 in Esophageal Squamous Cell Carcinoma Cases. Asian Pacific Journal of Cancer Prevention. 14(3). 1803–1806. 4 indexed citations

19.

Feng, Ji‐Feng, Ying Huang, & Qiang Zhao. (2013). Tumor length in elderly patients with esophageal squamous cell carcinoma: Is it a prognostic factor?. Upsala Journal of Medical Sciences. 118(3). 145–152. 25 indexed citations

20.

Feng, Ji‐Feng, et al.. (2012). Primary small cell carcinoma of the lesser omentum. The Kaohsiung Journal of Medical Sciences. 28(2). 115–119. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact